Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion [3]

Bone Marrow Transplantation

Volumn 41, Issue 1, 2008, Pages 95-96

  Junior A M ^a   Arrais, C A ^a   Saboya, R ^a   Velasques, R D ^b   Junqueira, P L ^b   Dulley, F L ^b  

^a FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMUSTINE; CISPLATIN; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DIMETHYL SULFOXIDE; DIPHENHYDRAMINE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; MELPHALAN; PHENYTOIN; VINBLASTINE;

ADULT; CASE REPORT; CRYOPRESERVATION; DRUG MEGADOSE; ELECTROENCEPHALOGRAM; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LETTER; LOADING DRUG DOSE; LUNG INFECTION; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE;

CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MIDDLE AGED; NEUROTOXICITY SYNDROMES;

EID: 38349048223     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705883     Document Type: Letter

References (9)

1. Rowley SD. Hematopoietic stem cell cryopreservation. In: Thomas ED, Storb R, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Scientific Inc: Malden, MA, USA, 1998, pp 481-492.
2. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521-526.
3. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705-4708.
4. Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533-537.
5. Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000; 25: 173-177.
6. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA. Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994; 45: 187-199.
7. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285-1287.
8. Higman MA, Port JD, Bezuchamp Jr NJ, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26: 797-800.
9. Bawens D, Hantson P, Laterre PF, Michaux L, Latinne D, Tourtchaninoff M et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005; 46: 1671-1674.